Newsroom

First Vaccine to Use SPHEREON®Technology Now Available SUMMIT, NEW JERSEY, September 15, 2014 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced that, following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted the marketing authorization for the veterinary […]

Read more

SUMMIT, N.J., September 9, 2014 – Merck Animal Health today announced the introduction of PRIME PAC™ PRRS+, a vaccine for reducing clinical signs of reproductive disease in female breeding-age swine and respiratory disease in pigs 3 to 4 weeks of age and older due to porcine reproductive and respiratory syndrome virus (PRRSv).PRRS continues to be […]

Read more

SUMMIT, N,.J., September 3, 2014 – In support of its commitment to 4-H, education and the development of the next generation of industry leaders, Merck Animal Health has proudly sponsored the inaugural Young Advocates for Agriculture Award. Through this award, high school students are recognized for their grass roots advocacy efforts in support of the […]

Read more

Summit, N.J., August 20, 2014 – Merck Animal Health today announced that Elizabeth Adams, D.V.M., has joined its Dairy Technical Services team. Prior to joining the company, Dr. Adams owned and operated an ambulatory dairy veterinary practice, as well as served as a veterinary consultant, providing herd health consultations on large dairies in Central Valley […]

Read more

Summit, N.J., July 22, 2014 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, today announced that new studies about ZILMAX® (zilpaterol hydrochloride), an FDA-approved feed supplement for cattle, will be presented at the Joint Annual Meeting of the American Society of Animal Science, American Dairy Science Association and Canadian […]

Read more

AMES, Iowa, June 16, 2014 – Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) conditional licensure of the company’s Porcine Epidemic Diarrhea Virus (PEDv) Vaccine, RNA utilizing its SirraVaxSM RNA Particle Technology. This is the first USDA conditional license granted for a PEDv vaccine since the […]

Read more

First Chewable Tablet for Dogs Effective for 12 Weeks* Against Fleas and Ticks SUMMIT, NJ, May 20, 2014 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the U.S. Food and Drug Administration’s approval of BRAVECTO™ (fluralaner) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, […]

Read more